🔎 Trials Near Me

Utama › Kanser Payudara › Iowa › Cedar Rapids

Kajian klinikal Kanser Payudara di Cedar Rapids, IA

17 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Cedar Rapids (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Mengambil pesertaFasa 1/2
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06324357

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Local Institution - 0065, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06618287

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Mengambil pesertaFasa 3
  • University of Iowa, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

Mengambil pesertaFasa 1
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06756932

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Mengambil pesertaFasa 3
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauh
Umur 18 hingga 60 · Wanita · Dikemas kini 2 Sep 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • University of Iowa, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07029399

Exercise Oncology Clinic Pilot Feasibility Trial

Mengambil peserta
  • University of Iowa Health Care, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT07765927

Breast Cancer PSMA PET

Mengambil pesertaFasa awal 1
  • University of Iowa Healthcare, Iowa City · 25 mi jauh
Umur 18 hingga 90 · Wanita · Dikemas kini 6 Ogo 2026 · NCT06586047

E-Mindfulness Approaches for Living After Breast Cancer

Mengambil pesertaFasa 3
  • Saint Luke's Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauh
Umur 18 hingga 50 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06748222

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Iowa, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Mengambil pesertaFasa 4
  • Iowa Holden Comprehensive Cancer Center, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT06169371

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Mengambil pesertaFasa 1
  • University of Iowa Health Care, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05283330

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Mengambil pesertaFasa 3
  • Saint Luke's Hospital, Cedar Rapids
Umur 50 hingga 70 · Semua jantina · Dikemas kini 23 Apr 2026 · NCT04852887

Quantitative MRI Assessment of Breast Cancer Therapy Response

Mengambil pesertaKajian pemerhatian
  • University of Iowa, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Apr 2026 · NCT05704062

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Physicians' Clinic of Iowa PC, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Iowa City · 25 mi jauh
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Payudara di bandar lain

Kajian lain di Cedar Rapids

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.